Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017039311) COMPOSITION FOR INTRACELLULAR DELIVERY CONTAINING ADENOVIRUS PROTEIN VI-DERIVED PEPTIDE AND ANTICANCER PHARMACEUTICAL COMPOSITION CONTAINING SAME
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/039311 International Application No.: PCT/KR2016/009714
Publication Date: 09.03.2017 International Filing Date: 31.08.2016
IPC:
A61K 38/10 (2006.01) ,A61K 39/395 (2006.01) ,A61K 48/00 (2006.01)
[IPC code unknown for A61K 38/10][IPC code unknown for A61K 39/395][IPC code unknown for A61K 48]
Applicants:
한양대학교 산학협력단 INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY [KR/KR]; 서울시 성동구 왕십리로 222 한양대학교 Hanyang Univ., 222, Wangsimni-ro, Seongdong-gu, Seoul 04763, KR
Inventors:
윤채옥 YUN, Chae Ok; KR
Agent:
특허법인 다나 DANA PATENT LAW FIRM; 서울시 강남구 역삼로 3길 11 광성빌딩 신관 5층 5th Floor, New Wing, Gwangsung Bldg., 11, Yeoksam-ro 3-gil, Gangnam-gu, Seoul 06242, KR
Priority Data:
10-2015-012275631.08.2015KR
Title (EN) COMPOSITION FOR INTRACELLULAR DELIVERY CONTAINING ADENOVIRUS PROTEIN VI-DERIVED PEPTIDE AND ANTICANCER PHARMACEUTICAL COMPOSITION CONTAINING SAME
(FR) COMPOSITION POUR L'ADMINISTRATION INTRACELLULAIRE CONTENANT UN PEPTIDE DÉRIVÉ DE LA PROTÉINE VI DES ADÉNOVIRUS ET COMPOSITION PHARMACEUTIQUE CONTRE LE CANCER CONTENANT CE DERNIER
(KO) 아데노바이러스 단백질 VI 유래 펩티드를 포함하는 세포 내 전달용 조성물 및 이를 포함하는 항암용 약제학적 조성물
Abstract:
(EN) The present invention relates to a composition for intracellular delivery containing an adenovirus protein VI-derived peptide and an anticancer pharmaceutical composition containing the same. According to the present invention, the use of the peptide or peptide-polymer composite of the present invention improves intracellular delivery efficiency of a nucleic acid, a peptide, a polypeptide, an antibody, a chemical material, or a virus. Therefore, the peptide or peptide-polymer composite of the present invention can be favorably used as an intracellular delivery system for various therapeutics.
(FR) La présente invention concerne une composition pour l'administration intracellulaire contenant un peptide dérivé de la protéine VI des adénovirus et une composition pharmaceutique contre le cancer contenant ce dernier. Selon la présente invention, l'utilisation du peptide ou du composite peptide-polymère de la présente invention améliore l'efficacité de l'administration intracellulaire d'acides nucléiques, de peptides, de polypeptides, d'anticorps, de substances chimiques ou de virus. Par conséquent, le peptide ou le composite peptide-polymère de la présente invention peuvent être avantageusement utilisés en tant que système d'administration intracellulaire pour divers agents thérapeutiques.
(KO) 본 발명은 아데노바이러스 단백질 VI 유래 펩티드를 포함하는 세포 내 전달용 조성물 및 이를 포함하는 항암용 약제학적 조성물에 관한 것이다. 본 발명에 따르면, 본 발명의 펩티드 또는 펩티드-폴리머 복합체를 이용하는 경우, 핵산, 펩티드, 폴리펩티드, 항체, 화학물질 또는 바이러스의 세포 내 전달효율이 향상된다. 따라서 본 발명의 펩티드 또는 펩티드-폴리머 복합체는 다양한 치료제의 세포 내 전달체로 유용하게 사용될 수 있다.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Korean (KO)
Filing Language: Korean (KO)